U
FCSC

UBS’s Fibrocell Science Inc. FCSC Stock Holding History

UBS’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$6K Sell
132
-224
-63% -$10.5K ﹤0.01% 9343
2014
Q2 		$21K Buy
356
+348
+4,350% +$19.4K ﹤0.01% 8034
2014
Q1 		$1K Buy
+8
New +$620 ﹤0.01% 10259
2013
Q4 		– Sell
-55
Closed -$4K – 10957
2013
Q3 		$4K Buy
+55
New +$4.45K ﹤0.01% 9624

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Catalyst Capital Advisors Huntington, New York $6.03B AUM 24.5% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

UBS's FCSC Position: Q3 2014 in Review

UBS reduced its Fibrocell Science Inc. (FCSC) stake by 63% in Q3 2014, selling an estimated $10.5K and leaving 132 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #9343.

UBS first reported a position in FCSC in Q3 2013 and has held it in 4 quarters since. The position peaked at $21K in Q2 2014. 38 funds tracked by Wall St. Rank hold FCSC as of Q3 2014.

  • UBS held 132 shares of Fibrocell Science Inc. worth $6K as of Q3 2014.
  • UBS sold 224 Fibrocell Science Inc. shares in Q3 2014, an estimated $10.5K.
  • Fibrocell Science Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9343 holding.
  • UBS first reported a position in Fibrocell Science Inc. in Q3 2013 and has held it in 4 quarters since.
  • UBS's Fibrocell Science Inc. position peaked at $21K in Q2 2014.
  • 38 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.